Mean platelet volume in patients with major depression: Effect of escitalopram treatment

Journal of Clinical Psychopharmacology

Volumn 29, Issue 4, 2009, Pages 368-371

  Ataoglu, Ahmet ^a   Canan, Fatih ^a  

^a DUZCE UNIVERSITY   (Turkey)

Author keywords

Escitalopram; Major depressive disorder; Mean platelet volume; Platelet activity

Indexed keywords

ESCITALOPRAM;

ADULT; ARTICLE; CELL ACTIVITY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; FEMALE; HUMAN; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; THROMBOCYTE COUNT; THROMBOCYTE VOLUME;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BLOOD PLATELETS; CELL SIZE; CITALOPRAM; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET ACTIVATION; PLATELET COUNT; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 68449090719     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e3181abdfd7     Document Type: Article

References (30)

1. Musselman DL, Evans DL, Nemeroff CB. The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Psychiatry. 1998;55:580-592.
2. Glassman AH, Shapiro PA. Depression and the course of coronary artery disease. Am J Psychiatry. 1998;155:4-11.
3. Lesperance F, Frasure-Smith N, Juneau M, et al. Depression and 1-year prognosis in unstable angina. Arch Intern Med. 2000;160:1354-1360.
4. Lesperance F, Frasure-Smith N, Talajic M, et al. Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation. 2002;105:1049-1053.
5. Rumsfeld JS, Jones PG, Whooley MA, et al. Depression predicts mortality and hospitalization in patients with myocardial infarction complicated by heart failure. Am Heart J. 2005;150:961-967.
6. Musselman DL, Tomer A, Manatunga AK, et al. Exaggerated platelet reactivity in major depression. Am J Psychiatry. 1996;153:1313-1317.
7. Sherwood A, Hinderliter AL, Watkins LL, et al. Impaired endothelial function in coronary heart disease patients with depressive symptomatology. J Am Coll Cardiol. 2005;46:656-659.
8. Kim CK, Mcgorray SP, Bartholomew BA, et al. Depressive symptoms and heart rate variability in postmenopausal women. Arch Intern Med. 2005;165:1239-1244.
9. Nemeroff CB, Musselman DL. Are platelets the link between depression and ischemic heart disease? Am Heart J. 2000;140(suppl 4):57-62.
10. Serebruany VL, Gurbel PA, O'Connor CM. Platelet inhibition by sertraline and N-desmethylsertraline: a possible missing link between depression, coronary events, and mortality benefits of selective serotonin reuptake inhibitors. Pharmacol Res. 2001;43:453-462.
11. Atar D, Malinin A, Takserman A, et al. Escitalopram, but not its major metabolites, exhibits antiplatelet activity in humans. J Clin Psychopharmacol. 2006;26:172-177.
12. Yetkin E. Mean platelet volume not so far from being a routine diagnostic and prognostic measurement. Thromb Haemost. 2008;100:3-4.
13. Giles H, Smith REA, Martin JF Platelet glycoprotein Ilb/IIIa and size are increased in acute myocardial infarction. Eur J Clin Invest. 1994;24:69-72.
14. Endler G, Klimesch A, Saunder-Plassman A, et al. Mean platelet volume is an independent risk factor for myocardial infarction but not for coronary artery disease. Br J Haematol. 2002;117:399-404.
15. Bath P, Algert C, Chapman N, et al. Association of mean platelet volume with risk of stroke among 3134 individuals with history of cerebrovascular disease. Stroke. 2004;35:622-626.
16. Martin J, Bath PMW, Burr ML, et al. Increased platelet size following myocardial infarction is associated with subsequent death and nonfatal reinfarction. Lancet. 1991;338:1409-1411.
17. Greisenegger S, Endler G, Hsieh H, et al. Is elevated mean platelet volume associated with a worse outcome in patients with acute ischemic cerebrovascular events? Stroke. 2004;35:1688-1691.
18. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382-389.
19. Piletz JE, Zhu H, Madakasira S, et al. Elevated P-selectin on platelets in depression: response to bupropion. J Psychiatr Res. 2000;34:397-404.
20. Schins A, Hamulyak K, Scharpe P, et al. Whole blood serotonin and platelet activation in depressed post-myocardial infarction patients. Life Sci. 2004;76:637-650.
21. Nemeroff CB, Knight DL, Krishnan RR, et al. Marked reduction in the number of platelet-tritiated imipramine binding sites in geriatric depression. Arch Gen Psychiatry. 1988;45:919-923.
22. Hrdina PD, Bakish D, Ravindran A, et al. Platelet serotonergic indices in major depression: up-regulation of 5-HT2A receptors unchanged by antidepressant treatment. Psychiatry Res. 1997;66:73-85.
23. Serebruany VL, Glassman AH, Malinin AI, et al. Endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline Antidepressant Heart Attack Randomized Trial (SADHART) platelet substudy. Circulation. 2003;108:939-944.
24. Laine-Cessac P, Shoaay I, Garre JB, et al. Study of haemostasis in depressive patients treated with fluoxetine. Pharmacoepidemiol Drug Saf. 1998;7(suppl 1):54-57.
25. Alvarez JC, Gluck D, Arnulf I, et al. Decreased platelet serotonin transporter sites and increased platelet inositol triphosphate levels in patients with unipolar depression: effects of clomipramine and fluoxetine. Clin Pharmacol Ther. 1999;66:617-624.
26. Musselman DL, Marzec UM, Manatunga A, et al. Platelet reactivity in depressed patients treated with paroxetine: preliminary findings. Arch Gen Psychiatry. 2000;57:875-882.
27. Pollock BG, Laghrissi-Thode F, Wagner WR. Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment. J Clin Psychopharmacol. 2000;20:137-140.
28. Atar D, Malinin A, Pokov A, et al. Antiplatelet properties of escitalopram in patients with the metabolic syndrome: a dose-ranging in vitro study. Neurospsychopharmacology. 2007;32:2369-2374.
29. Coban E, Yilmaz A, Sari R. The effect of weight loss on the mean platelet volume in obese patients. Platelets. 2007;18:212-216.
30. Loke YK, Trivedi AN, Singh S. Meta-analysis: gastrointestinal bleeding due to interaction between selective serotonin uptake inhibitors and non-steroidal anti-inflammatory drugs. Aliment Pharmacol Ther. 2008;27:31-40.